Early BAFF Receptor Blockade Mitigates Murine Sjögren's Syndrome: Concomitant Targeting of CXCL13 and the BAFF Receptor Prevents Salivary Hypofunction

Clinical Immunology - United States
doi 10.1016/j.clim.2016.01.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prevention of Murine Antiphospholipid Syndrome by BAFF Blockade

Arthritis & Rheumatism
2008English

Lymphotoxin-Beta Receptor Blockade Reduces CXCL13 in Lacrimal Glands and Improves Corneal Integrity in the NOD Model of Sjögren's Syndrome

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2011English

The BAFF Receptor Transduces Survival Signals by Co-Opting the B Cell Receptor Signaling Pathway

Immunity
Infectious DiseasesAllergyImmunology
2013English

Metformin Improves Salivary Gland Inflammation and Hypofunction in Murine Sjögren’s Syndrome

Arthritis Research & Therapy
2019English

Management of Salivary Hypofunction in Sjögren’s Syndrome

Current Treatment Options in Rheumatology
RheumatologyAllergyImmunology
2015English

Crucial Role for BAFF-BAFF-R Signaling in the Survival and Maintenance of Mature B Cells

PLoS ONE
Multidisciplinary
2009English

The Important Role of T Cells and Receptor Expression in Sjögren's Syndrome

Scandinavian Journal of Immunology
MedicineImmunology
2013English

Integrated B Cell, Toll-Like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells

Journal of Immunology
AllergyImmunology
2018English

Targeting BAFF/BLyS in Lupus: Is the Glass Half-Full or Half-Empty?: Table 1

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy